Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Flexion_Therapeutics
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:CEO |
David Stack
|
| gptkbp:focusesOn |
non-opioid pain management
|
| gptkbp:formerName |
Pacira Biosciences
|
| gptkbp:founded |
2007
|
| gptkbp:headquartersLocation |
gptkb:Parsippany,_New_Jersey,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Exparel
|
| gptkbp:numberOfEmployees |
over 700
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockSymbol |
PCRX
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.pacira.com/
|
| gptkbp:bfsParent |
gptkb:Aisling_Capital
gptkb:Depocyt gptkb:Pacira_BioSciences |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pacira Pharmaceuticals
|